Ribociclib
Kisqali
返回商品目錄Kisqali（ribociclib）是一種標靶藥物，用於治療荷爾蒙受體陽性（HR+）、HER2陰性（HR+ HER2-）乳癌，特別適用於早期（高風險）或晚期/轉移性病例。它需與內分泌治療（芳香化酶抑制劑或氟維司群）合併使用，以抑制癌細胞生長。
有效成分
Kisqali 200mg
3 個套裝| 包裝 | 每片 | 特惠價 | Buy |
|---|---|---|---|
5
pills 免運費 | $117.00 | 僅需 $585.00 | |
3
pills 免運費 | $129.67 | 僅需 $389.00 | |
1
pills | $193.00 | 僅需 $193.00 |
您可能還喜歡
Kisqali is a targeted therapy used to treat hormone receptor-positive (HR+), HER2-negative (HER2-) breast cancer, specifically for advanced or metastatic cases or early-stage (II or III) high-risk cases. It is a CDK4/6 inhibitor that blocks proteins encouraging cancer growth.